X
Hepatitis drug wins award for cure rate and efficacy
https://pharmaphorum.com/news/hepatitis-drug-wins-award/
Hepatitis
US judge overturns Gilead $2.54bn patent infringement ruling
Federal judge throws out Merck’s patent claim against Gilead
NICE recommends MSD’s hep C pill
Cost-effectiveness body backs combination drug Zepatier.
After 2015’s ‘breakthrough’ year for pharma approvals, will 2016 see a dip?
Roche’s MS drug is among major drugs still to come in 2016.
Move to eradicate viral hepatitis
NOhep campaign supports action against hepatitis.
Gilead’s latest hep C therapy approved in EU
Firm hopes Epclusa will give an edge over rivals.
WHO agrees global effort to eliminate viral hepatitis by 2030
All of the WHO’s 194 member states have voted to eliminate viral hepatitis by 2030 as part of a global strategy.
